6381 — Anest Iwata Income Statement

0.000.00%

Last trade - 00:00

IndustrialsBalancedSmall CapSuper Stock

Annual income statement for Anest Iwata, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.

	2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Yuho	Yuho	Yuho	Yuho	Yuho
Standards:	JAS	JAS	JAS	JAS	JAS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	35,589	42,337	48,515	53,425	54,411
Cost of Revenue
Gross Profit	14,926	18,228	21,337	24,475	25,320
Selling / General / Administrative Expenses
Research And Development
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	32,280	37,602	42,637	47,272	48,912
Operating Profit	3,308	4,735	5,878	6,153	5,499
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	4,137	5,542	7,091	7,987	7,271
Provision for Income Taxes
Net Income After Taxes	3,044	4,149	5,270	5,935	5,367
Minority Interest
Net Income Before Extraordinary Items
Net Income	2,623	3,541	4,382	4,932	4,278
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	2,623	3,541	4,382	4,931	4,276
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	70.6	93.3	114	128	120
Dividends per Share